Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

Bibliographic Details
Main Authors: Folprecht, Gunnar, Hamann, Susanne, Schütte, Katharina, Trarbach, Tanja, Stoehlmacher-Williams, Jan, Ehninger, Gerhard
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223588/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223588/

Similar Items